Abnormalities in the levels of apolipoproteins commonly observed in MASLD patients include increased levels of ApoB100 or apoB, ApoB48 and ApoC-III [17]. This evidence concerns the gene APOB and metabolic dysfunction-associated steatotic liver disease.